S.2172: Medical Innovation Act of 2017

About This Bill

Bill Version

Bill Summary

Medical Innovation Act of 2017 This bill amends the Public Health Service Act to require certain drug manufacturers to make payments to fund research supported by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A drug manufacturer with over $1 billion in net income in a fiscal year that has entered into a settlement agreement in the previous five years with a federal agency regarding specified violations...

(Source: Library of Congress)

Bill Actions

Date Description
Nov. 29, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Nov. 29, 2017

Introduced in the Senate by Elizabeth Warren (D-Mass.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page